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Background. Rates of psychiatric disorders are highly prevalent among prison inmates, and recent evidence conﬁrms
over-representation of youths and adults with attention deﬁcit hyperactivity disorder (ADHD). The risk for psychiatric
co-morbidity may be greater among offenders with ADHD. We undertook a systematic review and meta-analysis of
reported rates of co-existing psychiatric morbidity with ADHD in prison samples.
Method. Studies published from 1980 to 2015 were identiﬁed using ﬁve bibliographic indexes, review articles and ref-
erence lists. Included studies had a deﬁned ADHD group and provided additional prevalence on at least one of the fol-
lowing: conduct disorder, substance use disorder, mood disorder, anxiety disorder, or personality disorder. We
performed meta-analytical estimates of the prevalence of each co-morbid disorder within ADHD, and estimated the
risk for co-existing disorders among prisoners with ADHD by pooling odds ratios (OR) with 95% conﬁdence intervals.
Results. Eighteen studies with data for 1615 with ADHD and 3128 without ADHD were included. The risk (OR) of all
psychiatric morbidity is increased among adult inmates with ADHD. Associations in youths with ADHD were restricted
to mood disorder (OR 1.89, 95% conﬁdence interval 1.09–3.28).
Conclusions. This study quantiﬁes the extent of co-morbidity presented by offenders with ADHD, especially adults. The
differences between risk estimates for youths and adults indicate an incremental effect in both frequency and severity for
the development of further co-morbid pathology through adulthood. The ﬁndings have implications for clinical inter-
vention and for criminal justice policy.
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Introduction
Attention deﬁcit hyperactivity disorder (ADHD) is
one of the most diagnosed mental health problems in
children; meta-analyses estimate a world pooled
prevalence of 5.3% in children and 2.5% in
adults (Polanczyk et al. 2007; Simon et al. 2009).
Characterized by difﬁculties of inattentiveness, hyper-
activity and impulsivity, it is associated with signiﬁ-
cant problems in personal, social and occupational
outcomes (Shaw et al. 2012). Co-morbid psychiatric
problems are common presentations in both children
and adults with ADHD (Pliszka, 1998) and a US
nationally representative household survey found
that adults with ADHD were ﬁve times more likely
to develop a mood disorder, four times more likely
to develop an anxiety disorder, and three times more
likely to develop substance use disorder (Kessler
et al. 2006). Individuals with these co-morbid disorders
are likely to experience greater occupational impair-
ment, compared to people with ADHD alone.
Compared with population rates, there is robust evi-
dence to support an over-representation of youths and
adults with ADHD in the criminal justice system, most
likely reﬂecting high rates of co-morbidity with con-
duct disorder (Langley et al. 2010). A meta-analysis
of 42 international studies reported that 30% and
26% of the youth and adult prison populations, re-
spectively, had clinically diagnosed ADHD (Young
et al. 2014). There were no signiﬁcant differences for
gender and age, which does not parallel the corre-
sponding differences observed in the general popu-
lation. With respect to age, the implication is that
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young offenders with ADHD who come into contact
with the criminal justice system remain within this sys-
tem as repeat offenders.
More generally, rates of psychiatric disorders are
over-represented among prisoners (Fazel & Seewald,
2012) and it seems that the risk for developing
co-morbid psychiatric disorders may be greater
among offenders with ADHD (Abram et al. 2003;
Einarsson et al. 2009; Young et al. 2011b; Gudjonsson
et al. 2012; Gonzalez et al. 2013, 2015). The confounding
effect of this high level of psychiatric co-morbidity is
very likely to inﬂuence the behaviour, management
and treatment of these individuals as, despite inter-
national guidelines (Seixas et al. 2012) and treatment
beneﬁts on ADHD symptoms (Shaw et al. 2012),
ADHD is rarely diagnosed and treated by offender
mental health teams, as concluded by a multi-agency
consensus on ADHD and offender management
(Young et al. 2011c). This problem needs to be
addressed, especially since outcomes of treatment for
ADHD may be highly effective, with both individual
(Ginsberg et al. 2012) and societal gains (Lichtenstein
et al. 2012).
It is therefore important to better estimate the risk of
the development of co-morbid disorders (including
type of disorder) among offenders with ADHD to in-
form healthcare practitioners, who in turn can deliver
more appropriate treatment, management and care
plans. Hence this study synthesized data obtained
from a systematic literature search performed to ascer-
tain the psychiatric co-morbid conditions associated
with a clinical diagnosis of ADHD in both youth and
adult prisoners using meta-analysis. Rates were com-
pared with prisoners without ADHD.
Method
Eligibility criteria
The systematic review was performed in accordance
with the Preferred Reporting Items for Systematic
reviews and Meta-Analyses (PRISMA guidelines)
(Liberati et al. 2009). Initial searches were carried out
in a variety of databases and websites to gain an
understanding of the amount of information available.
Reports published since 1980 and in English were
included.
Data sources
Searches were conducted in OvidSP Medline (1948 to
present) and EMBASE (1988 to present segment),
Datastar PsycINFO (unrestricted) and Social SciSearch
(1972 to date; limited to English and added since 1
January 1980), including the literature published be-
tween 1 January 1980 and 3 May 2011; the search
was further extended to 31 May 2014 on 25 June
2014. One additional study (Konstenius et al. 2015)
was added following reviewer feedback.
Search
Search terms were developed, reﬁned and tested for
relevance by cross-checking results against a list of
known relevant articles provided by the lead author.
The following descriptors were utilized in OvidSP
EMBASE (1988 to present segment): ADHD; attention
deﬁcit disorder; [EMTREE] crime; criminals; crimi-
nology; criminal behaviour; criminal justice; criminal
law; court; criminal psychology; delinquency; juvenile
delinquency; gang; legal evidence; legal procedure;
police; legal liability; mandatory programs; violence;
prisons; prisoner; probation; law enforcement; recidi-
vism; jurisprudence; punishment; offender; drug
abuse; drug misuse. Studies were examined to identify
those containing information about co-morbid psychi-
atric disorders in an incarcerated ADHD population.
Study selection
Articles obtained from the ﬁnal searches were ﬁrst
de-duplicated, then an inclusion/exclusion screening
process was undertaken based on the following ex-
clusion criteria: non-English-language articles, articles
published before 1980, animal studies, articles that
were not peer reviewed (e.g. dissertations), and articles
that obviously did not hold relevance (e.g. they did not
focus on ADHD or crime and/or contained information
about co-morbid psychiatric disorders).
Review articles pre-2006 were excluded, and post-
2006 reviews were kept with the sole purpose to exam-
ine bibliographies to check for any other articles not
identiﬁed in the search; these review articles were
not included in the ﬁnal prevalence calculation; only
primary research articles were included. Articles with
no abstract (including initial PsycINFO and Social
SciSearch search outputs) were also excluded unless
the title or other information (e.g. key terms) suggested
they may hold relevance. The inclusion/exclusion
review was ﬁrst completed based on title/abstract/
key words by two researchers, and if the relevance of
an article was unclear, the full text was retrieved before
a ﬁnal decision was made. Once the initial inclusion/
exclusion process was completed, the full texts of in-
cluded articles were retrieved for detailed evaluation
against eligibility criteria:
• Studies must use samples composed entirely of
incarcerated individuals.
• Studies must deﬁne a clear ADHD group, i.e. give
the prevalence of their sample who met diagnostic/
screening criteria for ADHD using a validated
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measure. Studies in adults which reported only
retrospective self-report of childhood symptoms
were not included due to the likelihood that the
rates would be overinﬂated (Young et al. 2014).
• Studies must give additional prevalence on at least
one of the following: conduct disorder, substance
use disorder, mood disorder, anxiety disorder, or
personality disorder. The studies must report these
variables by ADHD group status (or provide infor-
mation so that this can be deduced) so the character-
istics can be compared between an ADHD group
and a non-ADHD group from within the same
sample.
Data collection process
A data extraction sheet was developed in Microsoft
Excel. The full text publications were divided ran-
domly among two researchers who performed the
data extraction independently. Data were reviewed
for consistency and any queries were resolved by dis-
cussion among the researchers and the lead author.
The lead author also made the ﬁnal decision whether
to include/exclude data by reviewing the identiﬁed
publications. Some cohorts of prison populations
were published more than once (Retz et al. 2004; Rosler
et al. 2004; Young et al. 2009, 2011b; Gudjonsson et al.
2011, 2012). To avoid double counting data, multiple
reports of the same cohort were pieced together by jux-
taposing author names, sample sizes and rates of
co-morbidity.
Data items
For each included study, the following variables were
extracted:
(1) Number of people with ADHD and the selected
co-morbidities, (2) number of people without
ADHD but with the selected co-morbidities, (3)
number of people with ADHD but without the
selected co-morbidities, (4) number of people
with neither ADHD nor the co-morbidities, (5)
youth/underage and adult sample, (6) sex of sam-
ple. In addition to the co-morbidities that are
reported on, we attempted to obtain rates of autism
spectrum disorder and learning disability, but too
few papers reported on these diagnoses.
(2) It was noted that there was no clear deﬁnition
across publications on the age of an adult v. a
youth. For the purposes of this meta-analysis, we
designated 18 years to be the cut-off point for a
youth becoming an adult (i.e. youths were 418
years and adults were >18 years); papers reporting
youth data often cited 18 years as the upper limit of
the age range of participants. In those papers
where an age range was given that spanned this
cut-off point (e.g. 15–28 years), the mean (or me-
dian if mean was not provided) was used to
deﬁne whether the study population should be
listed as ‘youth’ or ‘adult’. For studies reporting
on both genders separately, information was
recorded as two separate observations (‘study
strata’) linked by the study number.
Quality control
To ascertain the validity of eligible publications, one of
the researchers checked and independently reviewed
all papers selected for data extraction and interpret-
ation consistency. Disagreements were resolved by
reviewing the data source and by discussion between
two reviewers.
Statistical analysis
First, pooled random effect meta-analysis estimates of
the prevalence of each psychiatric disorder within
participants with ADHD were computed. Second,
meta-analyses of risk for co-existing disorders among
prisoners with ADHD were performed calculating
pooled odds ratios (OR) with 95% conﬁdence intervals
(CIs).
Considering heterogeneity of ADHD assessment in
research, differences in the criminal justice population,
and sample characteristics across countries, a random-
effects model approach was established a priori. A
random-effects approach presupposes that studies are
too dissimilar to assume they theoretically come from
the same sample. Studies in each domain were pooled
using the DerSimonian & Laird (1986) method for ran-
dom effects meta-analysis. Heterogeneity is reported
by the I2 index, which describes the percentage of vari-
ation across studies that is from actual heterogeneity
rather than chance. The I2 statistic does not entirely de-
pend on the number of studies considered (Higgins &
Thompson, 2002). Values of 25, 50 and 75 respectively
denote low, moderate and high heterogeneity.
We explored the risk for co-morbidity overall and by
age group separately for each of the following psychi-
atric disorders: conduct disorder (CD), substance use
disorders (SUD), mood disorders (MD), anxiety disor-
ders (AD) and personality disorders (PD). PD was only
reported for adult studies. Subgroup analysis based on
gender was not possible due to the low number of stu-
dies that resulted by stratifying results for male, female
and mixed samples for each co-morbid category.
Abram et al. (2003) and Plattner et al. (2007) reported
their data separately by gender. We combined these
sources of data by performing a ‘within study’
meta-analysis, therefore obtaining a common standard
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error for all participants of those studies, which was
then used in the overall pooled meta-analyses and
meta-regressions.
Meta-regression was used to examine the impact of
age (continuous) and gender (male, female, mixed) as
covariates on the pooled OR calculated for co-existing
disorders. All analyses were performed using Stata
v. 13 (StataCorp, USA) metan and metareg commands.
Results
In total, 9410 publications were identiﬁed following
the OvidSP Medline, EMBASE, Datastar, PsycINFO
and Social SciSearch database search. One additional
publication was added through personal communi-
cation. Publications not speciﬁcally relating to ADHD
and criminality and duplicates between databases
were excluded electronically, leaving 339. Once further
duplicates had been identiﬁed manually, 325 publica-
tions remained for which the full text was retrieved.
281 publications were further excluded as they did
not report on incarcerated ADHD samples and/or did
not provide associated co-morbid disorders data.
A further 26 studies were then removed for the fol-
lowing reasons: (1) used inadequate methods to assess
ADHD status (e.g. studies that only used retrospective
symptom assessment, self-report of ‘behavioural prob-
lems’ as a child, no consideration of childhood symp-
toms before adulthood diagnosis given, ADHD and
speciﬁc developmental disorder considered synony-
mous; nine studies), (2) provided co-morbid infor-
mation but only for the whole sample, not speciﬁed
by ADHD status (six studies), and (3) did not have
an adequate control group (i.e. all included partici-
pants had ADHD, or the control comparison group
was not incarcerated; ﬁve studies). Although data on
ADHD and CD were provided, we excluded
Forehand et al. (1991) from this analysis because all
their cases had CD (i.e. two 0 count cells). Data from
Chang et al. (2007) speciﬁc to SUD were also removed
because all their cases were co-morbid with ADHD.
For those papers that presented the co-morbidity
data continuously (e.g. as T scores, mean scores on di-
agnostic screens, etc.; six authors relating to eight stu-
dies), the author was contacted to attempt to gain
rates for the co-morbid diagnosis (i.e. number of parti-
cipants who fulﬁlled clinical criteria). One author
responded with additional data relating to a study con-
ducted in Scotland (Gudjonsson et al. 2012), which was
subsequently included in the meta-analysis. The re-
maining ﬁve studies were excluded as their data
could not be meaningfully utilized.
Thus, a total of 18 studies of prisoners with/without
ADHD and co-morbid disorders were selected to pro-
vide data for the meta-analysis (see Fig. 1 for a ﬂow
chart of the manual screening process). These 18 stu-
dies included nine adult and nine youth studies, for
a combined sample of 1615 participants with ADHD
and 3128 without the disorder (See Table 1). For each
co-morbid category, pooled effects are presented by
the overall sample of studies, followed by subgroup
analysis for youth and adult samples.
Pooled random-effects meta-analysis estimates
Table 2 shows all pooled prevalence rates and 95% CIs
of co-morbid disorders. Among youths with ADHD,
pooled prevalence rates of CD, SUD, MD, depression
and AD were 61%, 70%, 25%, 13% and 21%, respect-
ively. In adults with ADHD, the respective prevalence
rates were 29%, 74%, 66%, 55%, 68% and 60% for per-
sonality disorders.
Meta-analyses of risk for co-existing disorders
Conduct disorder
Seven studies (Kaplan & Cornell, 2004; Gordon &
Moore, 2005; Chang et al. 2007; Stahlberg et al. 2010;
Westmoreland et al. 2010; Young et al. 2011a; Grieger
& Hosser, 2012) provided data on the association be-
tween ADHD and CD (Fig. 2a). The overall association
was not signiﬁcant (OR 1.16, 95% CI 0.61–2.20).
Subgroup analysis by youth and adult studies revealed
no signiﬁcant pooled effects for youth samples, but a
signiﬁcant effect based on two adult studies (OR
2.10, 95% CI 1.19–3.70; Fig. 3a]. Heterogeneity was
high in youth studies and low in adults (I2 = 77.1 v.
33.9%).
Substance use disorders
Eleven studies (Milin et al. 1991; Abram et al. 2003; Retz
et al. 2004; Gordon &Moore, 2005; Einarsson et al. 2009;
Rosler et al. 2009; Stahlberg et al. 2010; Westmoreland
et al. 2010; Young et al. 2011b; Grieger & Hosser,
2012; Konstenius et al. 2015) provided data on the as-
sociation between ADHD and SUD (Fig. 2b). There
was a signiﬁcant overall effect size (OR 2.48, 95% CI
1.30–4.72), with substantial heterogeneity (I2 = 84.3%).
Subgroup analysis indicated a signiﬁcant pooled effect
for adults (OR 2.41, 95% CI 1.22–4.79) but not for
youths (OR 2.28, 95% CI 0.73–7.12). Heterogeneity
was high (I2 = 91.9%) in youth studies and moderate
(I2 = 54.8%) in adults (Fig. 3b).
Mood/affective disorders and depression
Twelve studies (Eyestone & Howell, 1994; Abram et al.
2003; Gordon & Moore, 2005; Anckarsater et al. 2007;
Chang et al. 2007; Plattner et al. 2007; Einarsson et al.
2009; Rosler et al. 2009; Stahlberg et al. 2010;
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Westmoreland et al. 2010; Young et al. 2011b;
Konstenius et al. 2015) provided data on mood/affect-
ive disorders, which included depression, mania and
adjustment disorder with associated mood symptoms
(Fig. 2c). The overall effect size was signiﬁcant (OR
2.96, 95% CI 1.86–4.71), with moderate heterogeneity
(I2 = 64.2%, p = 0.001). The pooled effect was signiﬁcant
for studies in youth (OR 1.89, 95% CI 1.09–3.28) and
adults (OR 4.50, 95% CI 2.69–7.51), with low hetero-
geneity in both (youth I2 = 48.3%; adults I2 = 39.0%)
(Fig. 3c).
To partial-out how much of the effect of mood disor-
ders was likely due to depression, we performed a
meta-analysis on nine studies (Eyestone & Howell,
1994; Gordon & Moore, 2005; Anckarsater et al. 2007;
Chang et al. 2007; Einarsson et al. 2009; Stahlberg
et al. 2010; Westmoreland et al. 2010; Young et al.
2011b; Konstenius et al. 2015) that provided data
speciﬁc for depressive disorder (Fig. 2d). The overall ef-
fect size was signiﬁcant (OR 3.00, 95% CI 1.70–5.29),
with moderate heterogeneity (I2 = 62.9%). The effect
of ADHD on depression was not signiﬁcant in youth
participants (OR 1.59, 95% CI 0.61–4.14) but was sign-
iﬁcant in adults (OR 4.66, 95% CI 2.92–7.45), with mod-
erate and no heterogeneity, respectively (youth I2 =
57.3%; adults I2 = 24.5%).
Anxiety disorders
On the seven studies(Abram et al. 2003; Chang et al.
2007; Einarsson et al. 2009; Rosler et al. 2009;
Stahlberg et al. 2010; Westmoreland et al. 2010; Young
et al. 2011b) with data on associations between
ADHD and AD (Fig. 2e), there was no signiﬁcant
Fig. 1. Flow diagram of the manual screening process for eligible literature inclusion.
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Table 1. Summary of characteristics of studies included in the meta-analyses, by psychiatric disorders and pooled co-morbidity rates, by
psychiatric disorders
Study (year) Gender Age group
Age
(x¯)
ADHD/
total
Co-morbidity/
total
Co-morbidity rates/
ADHD
Conduct disorder
Chang et al. (2007) Males 418 17.7 37/59 44/59 24/37
Gordon & Moore (2005) Males 418 16.0 92/453 247/453 53/92
Kaplan & Cornell (2004) Males 418 16.0 30/122 52/122 7/30
Stahlberg et al. (2010) Mixed 418 16.3 47/100 77/100 36/47
Young et al. (2011a) Males 418 14.6 23/54 33/54 19/23
Grieger & Hosser (2012) Males Adult 19.0 55/275 58/275 15/55
Westmoreland et al. (2010) Mixed Adult 29.2 68/319 56/319 21/68
Substance use disorders
Abram et al. (2003) Males 418 14.0 524/1170 604/1170 387/524
Abram et al. (2003) Females 418 14.0 317/656 303/656 205/317
Gordon & Moore (2005) Males 418 16.0 92/453 351/453 74/92
Milin et al. (1991) Mixed 418 15.5 21/111 90/111 21/21a
Stahlberg et al. (2010) Mixed 418 16.3 47/100 55/100 25/47
Einarsson et al. (2009) Males Adult 31.0 27/90 55/90 22/27
Grieger & Moore (2012) Males Adult 19.0 55/275 89/275 18/55
Konstenius et al. (2015) Females Adult 39.7 16/56 39/56 16/16a
Retz et al. (2004) Males Adult 18.8 28/129 109/129 25/28
Rosler et al. (2009) Females Adult 34.0 11/94 49/94 9/11
Westmoreland et al. (2010) Mixed Adult 29.2 68/319 286/319 67/68
Young et al. (2011b) Males Adult 30.0 27/198 108/198 16/27
Mood disorders
Abram et al. (2003) Males 418 14.0 524/1170 150/1170 145/524
Abram et al. (2003) Females 418 14.0 317/656 144/656 102/317
Anckarsater et al. (2007) Mixed 418 16.2 51/130 17/130 4/51
Chang et al. (2007) Males 418 17.7 37/59 6/59 5/37
Gordon & Moore (2005) Males 418 16.0 92/453 148/453 39/92
Plattner et al. (2007) Males 418 16.5 108/266 50/266 29/108
Plattner et al. (2007) Females 418 17.8 17/53 19/53 8/17
Stahlberg et al. (2010) Mixed 418 16.3 47/100 20/100 14/47
Einarsson et al. (2009) Males Adult 31.0 27/90 29/90 13/27
Eyestone & Howell (1994) Males Adult 40.0 48/88 49/88 38/48
Konstenius et al. (2015) Females Adult 39.7 16/56 24/56 9/16
Rosler et al. (2009) Females Adult 34.0 11/94 53/94 8/11
Westmoreland et al. (2010) Mixed Adult 29.2 68/319 173/319 59/68
Young et al. (2011b)b Males Adult 30.0 27/196 38/196 12/27
Depressive disorder
Anckarsater et al. (2007) Mixed 418 16.2 51/130 17/130 4/51
Chang et al. (2007) Males 418 17.7 37/59 6/59 5/37
Gordon & Moore (2005) Males 418 16.0 86/436 20/436c 6/86
Stahlberg et al. (2010) Mixed 418 16.3 47/100 20/100 14/47
Einarsson et al. (2009) Males Adult 31.0 27/90 19/90 9/27
Eyestone & Howell (1994) Males Adult 40.0 48/88 49/88 38/48
Konstenius et al. (2015) Females Adult 39.7 16/56 24/56 9/16
Westmoreland et al. (2010) Mixed Adult 29.2 68/319 74/319 34/68
Young et al. (2011b)b Males Adult 30.0 27/196 21/196 8/27
Anxiety disorders
Abram et al. (2003) Males 418 14.0 524/1170 230/1170 182/524
Abram et al. (2003) Females 418 14.0 317/656 206/656 126/317
Chang et al. (2007) Males 418 17.7 37/59 15/59 5/37
Stahlberg et al. (2010) Mixed 418 16.3 47/100 18/100 6/47
Einarsson et al. (2009) Males Adult 31.0 27/90 24/90 11/27
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overall effect (OR 1.82, 95% CI 0.78–4.28; I2 = 79.3%).
Stratiﬁcation revealed no effect in youth studies (OR
0.72, 95% CI 0.13–3.95; I2 = 84.9%), but was signiﬁcant
among adults (OR 3.58, 95% CI 2.32–5.53), with no het-
erogeneity (Fig. 3e).
Personality disorders
Only studies in adults (Black et al. 2004; Retz et al. 2004;
Einarsson et al. 2009; Rosler et al. 2009; Westmoreland
et al. 2010; Young et al. 2011b; Konstenius et al. 2015)
were considered for the effect size of the association
with PD (Fig. 2f). Seven studies showed a signiﬁcant
overall effect of ADHD in PD (OR 3.22, 95% CI 2.07–
5.01) with low heterogeneity (I2 = 37.6%).
Meta-regression. To further assess potential sources of
heterogeneity, the effect size (OR) of each co-morbid
category was regressed on age and gender. Age was
signiﬁcantly (p < 0.05) associated with an increase in
the OR between ADHD and mood/affective disorders
including depression. Age was not a signiﬁcant factor
on the remaining co-morbid categories. There were
no effects of gender on any of the effect sizes. The latter
result might be a reﬂection of low power to detect dif-
ferences in addition to a potential true ﬁnding.
Discussion
This systematic review of the prevalence of psychiatric
morbidity associated with ADHD in prison included
18 studies comprised of 1615 individuals with
ADHD and 3128 without the disorder. Subgroup
analysis allowed to partial out heterogeneity due to
age of participants, and its impact on the effect esti-
mates. Several keys ﬁndings were produced from this
review. First, the risk of (non-ADHD) psychopathology
is signiﬁcantly increased among adult prisoners with
ADHD compared with prisoners without ADHD.
Second, signiﬁcant associations with all psychiatric
morbidity categories were present in adult offenders
with ADHD, but in youth offenders these were limited
to mood/affective disorders, highlighting important
differences by age. Third, there was greater heterogen-
eity in effect sizes for youth samples.
Adult prevalence estimates of psychiatric co-
morbidity associated with ADHD were up to 74% for
SUD and lowest (29%) for CD. However, the largest
Table 1 (cont.)
Study (year) Gender Age group
Age
(x¯)
ADHD/
total
Co-morbidity/
total
Co-morbidity rates/
ADHD
Rosler et al. (2009) Females Adult 34.0 11/94 50/94 8/11
Westmoreland et al. (2010) Mixed Adult 29.2 68/319 136/319 46/68
Young et al. (2011b) Males Adult 30.0 27/198 120/198 24/27
Personality disordersd
Black et al. (2004) Mixed Adult 30.7 68/320 113/320 37/68
Einarsson et al. (2009) Males Adult 31.0 27/90 52/90 23/27
Konstenius et al. (2015) Females Adult 39.7 16/56 25/56 13/16
Retz et al. (2004) Males Adult 18.8 28/129 27/129 6/28
Rosler et al. (2009) Females Adult 34.0 11/94 28/94 7/11
Westmoreland et al. (2010) Mixed Adult 29.2 68/319 112/319 37/68
Young et al. (2011b) Males Adult 30.0 27/198 141/198 24/27
ADHD, Attention deﬁcit hyperactivity disorder
a Not included in the meta-analytic prevalence rate because of one 0 count cell.
b There were two missing cases on these co-morbidity rates.
c 17 cases excluded as questionable depression.
d Only adult studies included.
Table 2. Pooled random effects meta-analysis estimates of the
prevalence of psychiatric disorders co-existing with ADHD
418years Adults
Psychiatric co-morbidity Rate 95% CI Rate 95% CI
Conduct disorder 0.61 0.43–0.80 0.29 0.21–0.37
Substance use disorders 0.70 0.59–0.80 0.74 0.52–0.96
Mood disorders 0.25 0.16–0.34 0.66 0.50–0.81
Depressive disorder 0.13 0.05–0.21 0.55 0.35–0.76
Anxiety disorders 0.21 0.03–0.40 0.68 0.48–0.88
Personality disordersa – – 0.60 0.41–0.78
ADHD, Attention deﬁcit hyperactivity disorder; CI,
conﬁdence interval.
a Only adult studies included.
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effect sizes measured by OR were found for mood/af-
fective disorders with an almost 5-fold increase, and
anxiety disorders with more than a 3-fold increase in
the adult co-existence odds relative to non-ADHD
adult prisoners. Adult ADHD prisoners were twice
more likely than adult non-ADHD prisoners to have
a co-morbid history of CD, SUD and PD. For youth
offenders, risk was increased 3-fold for mood/affective
disorders. Contrary to expectations, CD was not asso-
ciated with ADHD in youth studies. This most likely
reﬂects that CD is a common co-morbidity in offender
samples in general and this combined problem there-
fore does not distinguish between prisoners with and
without ADHD, e.g. the prevalence estimates by
Chang et al. (2007), Stahlberg et al. (2010) and Young
et al. (2011b) reported rates of CD at 75%, 77% and
61%, respectively.
Surprisingly, there was a lack of association between
ADHD and SUD in youth studies. Nevertheless, con-
sidering the exceedingly high prevalence rate of SUD
in youths with ADHD (70%), it is likely that this nega-
tive ﬁnding was due to low power to detect potential
associations. The overall substantial prevalence of
co-morbidity between youth and adult prisoners with
ADHD, and the robust associations among adults,
suggest that SUD may be an important mediator in
the association between ADHD, delinquency and in-
carceration. Population studies indicate that 12.5% of
adults meet full DSM criteria for a SUD (Kessler et al.
2006). There is evidence that untreated ADHD is a pre-
dictor for the development of SUD (Wilens et al. 1997),
and pooled prevalence rates of ADHD at 23.1% have
been reported among treatment seeking substance de-
pendent patients (van Emmerik-van Oortmerssen et al.
2012). Indeed it is hypothesized that people with
undiagnosed or untreated ADHD engage in substance
misuse as a means of self-medication (Khantzian,
1985). The signiﬁcant effect for ADHD and co-morbid
mood/affective disorders (which included depression,
mania and suicidal behaviour) suggests that, com-
pared with non-ADHD peers, these youth offenders
with ADHD were three times more likely to develop
an affective disorder. Emotional dysregulation is
increasingly recognized as a presenting problem for
Fig. 2. Forest plots with overall odds ratios (OR), effect size (ES), and homogeneity statistics for meta-analyses of six domains
of co-morbid disorders.
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adults with ADHD (Gudjonsson et al. 2013) and the
pooled effects reported here suggest that emotional in-
stability presents from childhood in young offender
populations. This has implications for treatment as
emotional instability, low mood and substance misuse
are problems that are likely to hamper the rehabili-
tation process. When examining depression separately
however, we found an important distinction: adult, but
not youth offenders, had the greater risk (x5), which
has implications for the management of risk of suicide
within correctional services.
The strengths of this meta-analysis are the compre-
hensive review of studies and the range of psychiatric
disorders studied among youth and adult offenders
with and without ADHD. However, these ﬁndings
should be interpreted in the context of several limita-
tions. We found considerable variation from studies
conducted in youths, and heterogeneity that was unac-
counted for in some adult estimates. This may reﬂect
variation from differences in the methodology
employed in these studies, cultural differences and in
instruments used for the measurement of ADHD. The
latter has been found to produce important differences
in meta-analytical rates (Young et al. 2014). Increased
heterogeneity in minors may also reﬂect a process of
stabilization in the characteristics of adult inmate popu-
lations over time, may be due to more similar individ-
ual ‘types’ being repeat offenders or some convergence
of disorders with maturity. Additionally, extracted data
was not sufﬁcient to perform sensitivity analysis on po-
tential moderators, such as gender, or to model
meta-analytical regressions with sufﬁcient power on
all outcomes. For instance, limited amount of studies
performed in female inmates hinders our ability to con-
clude whether there is an absence of gender effects on
the meta-analytical regression estimates, or if we failed
to attain sufﬁcient power to detect such effects (i.e.
Type II error). We established rigorous criteria for the
ADHD assessment and excluded studies that only
used retrospective symptom assessment, but it was
not feasible to apply these same principles to the
measurement of the other psychiatric categories, there-
fore some variation in the estimates may derive from
their assessment.
This study adds to the evidence regarding the
co-morbid presentation of offenders with ADHD and
the ﬁndings have implications for clinical intervention
and for criminal justice policy. Clinical symptoms of
Fig. 3. Forest plots with odds ratios (OR), effect size (ES), and homogeneity statistics for meta-analyses of ﬁve domains of
co-morbid disorders stratiﬁed by age418 years and adult studies. Only adult studies for personality disorders, included in Fig. 2.
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ADHD in youth and adult offenders are often missed
or misdiagnosed (Baillargeon et al. 2010; Young et al.
2011c) and it seems that for youth offenders, ADHD
is most likely to be misdiagnosed as mood/affective
disorders. On the basis of these results, children with
ADHD in prison are likely to present additional
mood/affective disorders, which may manifest more
recognizable symptoms, thus making it likely that an
ADHD diagnosis goes unnoticed. Similar factors may
be at play for adults who are likely to present with ad-
ditional symptoms of mood, anxiety or substance use
disorders. Research suggests that the pathway from
ADHD to depression involves both anxiety and dis-
ruptive behaviour, and increases with age due to the
continued negative reactions of others to their ADHD
and disruptive symptoms (Roy et al. 2014). The differ-
ences between the effect estimates for youths and
adults found in the present study suggest an incremen-
tal effect (in both frequency and severity) for the devel-
opment of co-morbidities. It is likely that a cumulative
effect of psychiatric morbidity takes its toll on the
young person’s social and personal development, lead-
ing them to become emotionally less resilient and in-
creasing the risk for the development of clinical and
personality co-morbid pathology as they mature.
With re-offending rates related to psychiatric
co-morbidity (Baillargeon et al. 2010), the identiﬁcation
of effective interventions for this patient group should
be a primary concern. In developmental terms, onset of
ADHD symptoms most likely will onset before these
co-morbid conditions, therefore primary prevention
strategies targeting children at risk may help improve
long-term outcomes. Further research on this area
should aim to better understand the contribution of
ADHD and co-existing conditions in the pathways to
delinquency and crime.
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